NCT01492205View on ClinicalTrials.gov

NovoLet® Acceptance Study Within the Hospital Practise in Indonesia

CompletedOBSERVATIONAL
Enrollment

203

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DRUG

insulin human

All subjects were treated with human insulin administered either by using the NovoLet® pre-filled insulin system or the conventional vial and syringe method. Doctors and nurses must personally administer at least 10 insulin doses to each patient under their individual clinical supervision for assessment of the NovoLet® pre-filled insulin system

Trial Locations (1)

12520

Novo Nordisk Investigational Site, Jakarta

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01492205 - NovoLet® Acceptance Study Within the Hospital Practise in Indonesia | Biotech Hunter | Biotech Hunter